Sugammadex in children premedicated with dexamethasone

Recovery from rocuronium with sugammadex in children premedicated with dexamethasone for prevention of postoperative nausea and vomiting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201607001699405

Enrollment

Registered

2016-06-29

Start date

2015-08-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Recovery from premedication

Interventions

Metoclopromide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I and II patients 1-6 years strabismus surgery

Exclusion criteria

Exclusion criteria: Difficult airway Neuromuscular cardiac disease Hepatic disease Renal disease Metabolic disorder Steroidal or non-steroidal therapy

Design outcomes

Primary

Measure	Time frame
Investigate any possible efficacy alteration of sugammadex as a reversal of rocuronium due to dexamethasone injection in children undergoing strabismus surgery	—

Secondary

Measure	Time frame
Assess the safety of sugammadex in these groups of patients through close monitoring of the patients in the operating room and the Post Anesthesia Care Unit (PACU)	—

Countries

Egypt

Contacts

Public ContactMaha Ghanem

Alexandria Faculty of Medicine

maha.ghanem@alexmed.edu.eg+201223374415

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026